Insulin-like growth factor binding protein-3: Factors affecting binary and ternary complex formation

Growth Regulation

Volumn 6, Issue 1, 1996, Pages 42-47

  Holman, S R ^a   Baxter, R C ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Acid labile subunit; Association constant; IGF binding protein 3; Insulin like growth factor; Physiological conditions; Ternary complex

Indexed keywords

PHOSPHATE; SODIUM CHLORIDE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; COMPLEX FORMATION; IONIC STRENGTH; PH; TEMPERATURE;

ADULT; BINDING, COMPETITIVE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KINETICS; MACROMOLECULAR SUBSTANCES; OSMOLAR CONCENTRATION; RECOMBINANT PROTEINS; THERMODYNAMICS;

EID: 0029877064     PISSN: 0956523X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Martin J L, Baxter R C. Insulin-like growth factor binding protein from human plasma: purification and characterization. J Biol Chem 1986; 261: 8754-8760.
2. Martin J L, Baxter R C. Antibody against acid-stable insulin-like growth factor binding protein detects 150 000 mol wt growth hormone-dependent complex in human plasma. J Clin Endocrinol Metab 1985; 61: 799-801.
3. Zapf J, Waldvogel M, Froesch E R. Binding of nonsuppressible insulinlike activity to human serum: Evidence for a carrier protein. Arch Biochem Biophys 1975; 168: 638-645.
4. Hintz R L, Liu F. Somatomedin plasma binding proteins. In: Pecile A, Müller E E (eds), Growth hormone and other biologically active peptides. Amsterdam: Excerpta Medica, 1980: 133-143.
5. Furlanetto R W. The somatomedin C binding protein: Evidence for a heterologous subunit structure. J Clin Endocrinol Metab 1980; 51: 12-19.
6. Wilkins J R, D'ErcoIe A J. Affinity-labeled plasma somatomedin-C/insulin-like growth factor I binding proteins: Evidence of growth hormone dependence and subunit structure. J Clin Invest 1985; 75: 1350-1358.
7. Baxter R C, Martin J L, Beniac V A. High molecular weight insulin-like growth factor binding protein complex: Purification and properties of the acid-labile subunit from human serum. J Biol Chem 1989; 264: 11843-11848.
8. Baxter R C, Martin J L. Structure of the Mr 140000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity labeling. Proc Nail Acad Sei USA 1989; 86: 6898-6902.
9. Hardouin S, Hossenlopp P, Segovia B, Seurin D, Portolan G, Lassarre C, Binoux M. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. Eur J Biochem 1987; 170: 121-132.
10. Sommer A, Spratt S K, Tatsuno G P, Tressel T, Lee R, Maack C A. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Growth Reg 1993; 3: 46-49.
11. Rapp R, Deger A, Blum W, Koch R, Weber U. Characterization of the protein which binds insulin-like growth factor in human serum. Eur J Biochem 1988; 172: 421-425.
12. Baxter R C. Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex. Biochem J 1990; 271: 773-777.
13. Baxter R C, Bayne M L, Cascieri M A. Structural determinants of binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3. J Biol Chem 1992; 267: 60-65.
14. Hunston D L. Two techniques for evaluating small molecule-macromolecule binding in complex system. Anal Biochem 1975; 63: 99-109.
15. Guler H-P, Zapf J, Schmid C, Froesch E R. Insulinlike growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol. 1989; 121: 753-758.
16. Young S C J, Miles M V, Clemmons D R. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. Endocrinology 1992; 131: 1867-1873.
17. Lewitt M S, Saunders H, Phuyal J L, Baxter R C. Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology 1994; 134: 2404-2409.
18. Baxter R C. Insulin-like growth factor binding proteins in the human circulation: A review. Horm Res 1994; 42: 140-144.
19. Baxter R C. The somatomedins: Insulin-like growth factors. Adv Clin Chem 1986; 25: 49-115.
20. Binoux M, Lalou C, Lassarre C, Segovia B. Regulation of IGF bioavailability by IGFBP proteases. In: Baxter R C, Gluckman P D, Rosenfeld R G (eds). The insulin-like growth factors and their regulatory proteins. Amsterdam: Excerpta Medica, 1994: 217-226.